ZTS Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Zoetis Inc. Class Acton Lawsuit

Robbins LLP is reminding investors of the July 27, 2026 lead plaintiff deadline in a class action lawsuit against Zoetis Inc. The lawsuit alleges that Zoetis misled investors about declining sales of flagship products including Librela, Simparica Trio, Apoquel, and Cytopoint due to FDA safety warnings, market competition, and market share losses. The company's stock fell 21.5% following disappointing Q1 2026 results and reduced full-year guidance.